Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, Lpcn 1154
Lipocine宣佈完成產後抑鬱症候選藥物的關鍵研究 Lpcn 1154 的給藥
Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, Lpcn 1154
Lipocine宣佈完成產後抑鬱症候選藥物的關鍵研究 Lpcn 1154 的給藥
使用瀏覽器的分享功能,分享給你的好友吧